Press Releases

Archives

February 11, 2015 – Clinilabs, a contract research organization that provides clinical development services to industry has launched a charitable campaign called “Clinilabs Gives Back.”  This campaign will begin with a month-long canned food drive for homeless senior citizens on February 17th.  Can collection will be held at both Clinilabs locations, Manhattan and Eatontown, NJ).

February 9, 2015 - Clinilabs, Inc., is proud to be a platinum sponsor for the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2015 Annual Meeting.  This event is scheduled to take place at the Hyatt Regency in New Orleans, Louisiana from March 3rd through the 7th.

November 7, 2014 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, announced today the launch of a free flu shot program for Senior Citizens.  The vaccines are available by appointment only, on Wednesdays and Thursdays, at both of the company’s locations.

September 29, 2014 - Clinilabs is pleased to announce that it has entered into an agreement with Comprehensive Clinical Development to support Comprehensive’s inpatient psychiatric  trials at their Queens, New York site with Principal Investigator, Dr. Aggy Vallanat.   Under this agreement, Comprehensive now has access to Clinilabs’ Phase 1 unit in New York City for the execution of inpatient psychiatric studies.

May 9, 2014 - Clinilabs, a contract research organization that provides early-phase and specialty clinical drug development services to industry, announced today that they have initiated an Asian Bridging study to evaluate the safety, tolerability and pharmacokinetics of an investigational medication for the treatment of female infertility.

April 11, 2014 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, announced today the arrival of Mina Pastagia, MD, MS to the team.  Dr. Pastagia has assumed the position of Medical Director and Principal Investigator at the company’s Phase I unit in New York City.

February 11, 2014 - Clinilabs, a contract research organization that provides early-stage and specialty clinical drug development services to industry, announced today that they have begun offering comprehensive human abuse liability (HAL) testing at their Phase 1 units in NYC and NJ.  The company introduced the service in 2013, and is releasing information at this year’s ASCPT conference, where they will be in attendance as a Platinum Sponsor for the 7th consecutive year.

September 30, 2013 - Clinilabs, a contract research organization that provides early-stage and specialty clinical drug development services to industry, announced today that they have begun a Phase I clinical research study of an investigational medication for Type 2 Diabetes Mellitus.  The study is being conducted to assess the safety and tolerability of multiple daily doses of the investigational medication over periods of up to 28 days. 

September 13, 2013 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, announced today the arrival of Dr. Xiang Zhou to the team.  Dr. Zhou will be one of the team leaders in Clinilabs’ biomarker program, and will be supporting Phase I biomarker trials conducted at the company’s Phase I units in NY and NJ.

September 5, 2013 - Clinilabs, a contract research organization that provides early-phase and specialty clinical drug development services to industry, announced today that they will sponsor the American Diabetes Association’s (ADA) Step Out: Walk to Stop Diabetes this September.

April 29, 2013 – Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced the arrival of Dr. Admir Hadžić to the Clinilabs team.  Dr. Hadžić will provide expertise in the development of drugs to treat pain, and also will manage the collection of CSF/cCSF samples in clinical trials.

April 2, 2013 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced that it has launched a subject authentication initiative at its Phase 1 sites in New York and New Jersey.

October 11, 2012 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced the arrival of Ms. Melissa Buckland to the position of Director of Phase I Services.

September 6, 2012 - Clinilabs announced today that they have completed a clinical research study characterizing the pharmacokinetic profile of an investigational medication in healthy Japanese and non-Japanese subjects by assessing serum drug concentrations over time.

June 4, 2012 - Clinilabs, an early phase clinical drug development services to industry, today announced the arrival of Daniel P. van Kammen, MD, PhD, FACNP  to the Scientific Advisory Board.   

May 24, 2012 - Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I unit in Southern New Jersey.

March 9, 2012 - Clinilabs is proud to be a Platinum Sponsor for its 4th consecutive year and hosting the President's Reception for the 2012 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).